Portfolio company
Transquis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops small molecule therapeutics that reprogram dysfunctional myeloid immune cells to treat patients with neurodegenerative and aging-related diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vanqua Bio
This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Deciduous Therapeutics
This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.
Yumanity Therapeutics
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
AstronauTx
This biotechnology company develops small-molecule drugs targeting astrocyte biology to treat patients with Alzheimer's disease and other neurodegenerative disorders.
PharmatrophiX
The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.
Trimtech Therapeutics
This biotechnology company develops small molecule drugs that target and degrade toxic protein aggregates to treat neurodegenerative and inflammatory diseases.
MindImmune
This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.
